Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 10, 2012, Pages 2409-2417

  Baugh, Stephanie ^a   Ekanayaka, Aruna S ^a   Piddock, Laura J V ^a   Webber, Mark A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

ABC; Curli; Efflux inhibitor; MATE; MFS; RND

Indexed keywords

ACRB PROTEIN; ACRD PROTEIN; ACREF PROTEIN; ARGININE DERIVATIVE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CHLORPROMAZINE; CONGO RED; EMRAB PROTEIN; MDFA PROTEIN; MDSABD PROTEIN; MDTABC PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PHENYL ARGININE BETA NAPHTHYLAMIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM MUTANT; BIOFILM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; WILD TYPE;

ANTI-BACTERIAL AGENTS; BIOFILMS; BIOLOGICAL TRANSPORT, ACTIVE; COLORING AGENTS; CONGO RED; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION PROFILING; GENTIAN VIOLET; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, ELECTRON, SCANNING; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM; STAINING AND LABELING;

EID: 84866595537     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks228     Document Type: Article

References (37)

1. Branda SS, Vik A, Friedman L et al. Biofilms: the matrix revisited. Trends Microbiol 2005; 13: 20-6.
2. Watnick P, Kolter R. Biofilm, city of microbes. J Bacteriol 2000; 182: 2675-9.
3. Costerton JW, Cheng KJ, Geesey GG et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987; 41: 435-64.
4. An D, Parsek MR. The promise and peril of transcriptional profiling in biofilm communities. Curr Opin Microbiol 2007; 10: 292-6.
5. Lazazzera BA. Lessons from DNA microarray analysis: the gene expression profile of biofilms. Curr Opin Microbiol 2005; 8: 222-7.
6. Gomez MI, Prince A. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 2007; 7: 244-51.
7. Archer GL. Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices. Antimicrob Agents Chemother 1978; 14: 353-9.
8. Diederen BM. Legionella spp. and Legionnaires' disease. J Infect 2008; 56: 1-12.
9. Dismukes WE, Karchmer AW, Buckley MJ et al. Prosthetic valve endocarditis. Analysis of 38 cases. Circulation 1973; 48: 365-77.
10. Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 2004; 17: 413-33.
11. Lovegrove JM. Dental plaque revisited: bacteria associated with periodontal disease. J N Z Soc Periodontol 2004: 7-21.
12. Patterson FP, Brown CS. The McKee-Farrar total hip replacement. Preliminary results and complications of 368 operations performed in five general hospitals. J Bone Joint Surg Am 1972; 54: 257-75.
13. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 1975; 131: 543-52.
14. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007; 5: 48-56.
15. Sinnott CR, Teall AJ. Persistent gallbladder carriage of Salmonella typhi. Lancet 1987; 1: 976.
16. Vaishnavi C, Singh S, Kochhar R et al. Prevalence of Salmonella enterica serovar Typhi in bile and stool of patients with biliary diseases and those requiring biliary drainage for other purposes. Jpn J Infect Dis 2005; 58: 363-5.
17. Crull K, Rohde M, Westphal K et al. Biofilm formation by Salmonella enterica serovar Typhimurium colonizing solid tumours. Cell Microbiol 2011; 13: 1223-33.
18. Veldman A, Vahl HA, Borggreve GJ et al. A survey of the incidence of Salmonella species and Enterobacteriaceae in poultry feeds and feed components. Vet Rec 1995; 136: 169-72.
19. Vestby LK, Moretro T, Langsrud S et al. Biofilm forming abilities of Salmonella are correlated with persistence in fish meal and feed factories. BMC Vet Res 2009; 5: 20.
20. Hilborn ED, Mermin JH, Mshar PA et al. A multistate outbreak of Escherichia coli O157:H7 infections associated with consumption of mesclun lettuce. Arch Intern Med 1999; 159: 1758-64.
21. Soderstrom A, Osterberg P, Lindqvist A et al. A large Escherichia coli O157 outbreak in Sweden associated with locally produced lettuce. Foodborne Pathog Dis 2008; 5: 339-49.
22. Garcia B, Latasa C, Solano C et al. Role of the GGDEF protein family in Salmonella cellulose biosynthesis and biofilm formation. Mol Microbiol 2004; 54: 264-77.
23. Gerstel U, Romling U. The csgD promoter, a control unit for biofilm formation in Salmonella typhimurium. Res Microbiol 2003; 154: 659-67.
24. Latasa C, Roux A, Toledo-Arana A et al. BapA, a large secreted protein required for biofilm formation and host colonization of Salmonella enterica serovar Enteritidis. Mol Microbiol 2005; 58: 1322-39.
25. Piddock LJ. Multidrug-resistance efflux pumps-not just for resistance. Nat Rev Microbiol 2006; 4: 629-36.
26. Koronakis V, Eswaran J, Hughes C. Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu Rev Biochem2004; 73: 467-89.
27. Nikaido H. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 1996; 178: 5853-9.
28. Nikaido H, Takatsuka Y. Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta 2009; 1794: 769-81.
29. Paulsen IT, Brown MH, Skurray RA. Proton-dependent multidrug efflux systems. Microbiol Rev 1996; 60: 575-608.
30. Buckley AM, Webber MA, Cooles S et al. The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 2006; 8: 847-56.
31. Nishino K, Latifi T, Groisman EA. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol Microbiol 2006; 59: 126-41.
32. Webber MA, Bailey AM, Blair JM et al. The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. J Bacteriol 2009; 191: 4276-85.
33. Lau SY, Zgurskaya HI. Cell division defects in Escherichia coli deficient in the multidrug efflux transporter AcrEF-TolC. J Bacteriol 2005; 187: 7815-25.
34. Webber MA, Burrows C. The AcrAB-TolC efflux system contributes to biofilm formation in Salmonella enterica serovar Typhimurium. In: Abstracts of the Eighteenth European Conference on Clinical Microbiology and Infectious Diseases, Barcelona, 2008. Abstract P-707. Clin Microbiol Infect 2008; 14 Suppl S7: 179.
35. Kvist M, Hancock V, Klemm P. Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl Environ Microbiol 2008; 74: 7376-82.
36. Jonas K, Tomenius H, Kader A et al. Roles of curli, cellulose and BapA in Salmonella biofilm morphology studied by atomic force microscopy. BMC Microbiol 2007; 7: 70.
37. Lomovskaya O, Bostian KA. Practical applications and feasibility of efflux pump inhibitors in the clinic-a vision for applied use. Biochem Pharmacol 2006; 71: 910-8.